PhD Scholar - Immunooncology
Applications Close : 01 June 2023
Job Description
About the project
The research aims to optimise formulation of nanoparticles with immune active molecules. Initial testing will be conducted in immune cells (macrophages) in cell culture (in vitro). Nanoparticles will be designed to stimulate an immune receptor on the cell surface as well as deliver an RNA molecule into the cell that will further boost macrophage anti-tumour activity. We will then use in vivo models to identify dosing regimen by which immune stimulating nanoparticles safely achieve the best stimulation of tumour associated immune cells and reduction in tumour size.
More details can be found here:
About the lab
The Bartlett lab is located in the Hunter Medical Research Institute (HMRI) in partnership with the University of Newcastle (UoN) and you’ll be registered as a HDR at UoN, within the School of Biomedical Sciences and Pharmacy. The stipend ($40K for 4 years) is co-funded between NSW Health and the UoN.
The project will be co-supervised by Industry partner (Axelia Oncology) Chief Scientific Officer and will offer extensive insight in drug development and commercialisation via interaction with Axelia CEO and Brandon Capital Partners (venture capital) advisors and investors.
How to apply
Interested applicants should send an email expressing their interest along with scanned copies of their academic transcripts, CV, a brief statement of their research interests and a proposal that specifically links them to the research project.
Please send the email expressing interest to [email protected] by 5pm on 01 June 2023.
Required Skills
For further details contact
Nathan Bartlett
Email: [email protected]
